MiniMed, the diabetes business of medical device maker Medtronic , said on Thursday it has raised $560 million in its U.S. initial public offering.
The diabetes care company, which makes insulin pumps, glucose monitors and sensors, priced 28 million shares at $20 each, the lower end of its previously indicated $25-$28 range.
Sign up here.
Medtronic, which has a market capitalization of rough… [727 chars]
Source: Reuters | Published: 2026-03-06T00:44:20Z
Credit: Reuters
